Scientists from the National Institutes of Health are getting royalty payments from pharmaceutical and other private companies. A Congressional hearing this month even looked into this practice, which has happened for decades. But now there's a new push for more transparency to see who's getting paid for what. Adam Andrzejewski from OpentheBooks.com talks about the hurdles they've faced getting that information from the government.

See omnystudio.com/listener for privacy information.